Search

Search Constraints

You searched for: Author/Creator Leenstra, Sieger

Search Results

1. Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers. Issue 12 (26th May 2022)

2. DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA. (14th November 2022)

3. DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells. Issue 2 (28th January 2015)

4. DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells. Issue 2 (28th January 2015)

5. EXTH-15. DRUG SCREENING ON PATIENT GBM CELL CULTURES IDENTIFIES OMACETAXINE MEPESUCCINATE AS A POTENT ANTI-GLIOMA AGENT WITH THE ABILITY TO CROSS THE BLOOD-BRAIN-BARRIER. (14th November 2022)

6. Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures. Issue 1 (2nd August 2021)

8. Multiomics profiling of paired primary and recurrent glioblastoma patient tissues. Issue 1 (4th July 2020)

9. PATH-42. EGFR-AMPLIFIED IDH-WILDTYPE GLIOBLASTOMAS SELDOM TRANSFORM INTO A HYPERMUTATED PHENOTYPE. (5th November 2018)